SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trading with a market value of 3.22M, the company has a mix of catalysts and obstacles that spring from the nature of its operations.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) shares slumped -6.98% to finally closed at $0.13 in last active session.
SLS’s distance from 20 day simple moving average is -65.67% and distance from 50-Day simple moving average is -81.56%.
Analyst’s mean target price for SLS is $8.75 while analysts mean recommendation is 2.00. Stock value has moved between $0.13 – 4.33 in last one year. Stock has got OUTPERFORM rating from 1 of Thomson Reuters analysts, 1 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for SLS is $8.75 while analysts mean recommendation is 2.00.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) yearly performance is -97.41%. Annual EPS Growth of past 5 years is 63.30%. The current share price indicates that stock is -97.41% away from its one year high and is moving -1.54% ahead of its 52-week low.
On 25 June 2018, Taronis Technologies, Inc. (NASDAQ:TRNX) shares slumped -10.86% and ultimately finalized to $0.18 in last traded day. Stock has got OUTPERFORM rating from 1 of Thomson Reuters analysts, 0 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for TRNX is $6.50.
